BACKGROUND: The development of specific biomarkers to aid in the diagnosis and prognosis of neuronal injury is of paramount importance in cardiac surgery. Alpha II-spectrin is a structural protein abundant in neurons of the central nervous system and cleaved into signature fragments by proteases involved in necrotic and apoptotic cell death. We measured cerebrospinal fluid alpha II-spectrin breakdown products (alphaII-SBDPs) in a canine model of hypothermic circulatory arrest (HCA) and cardiopulmonary bypass. METHODS: Canine subjects were exposed to either 1 hour of HCA (n = 8; mean lowest tympanic temperature 18.0 +/- 1.2 degrees C) or standard cardiopulmonary bypass (n = 7). Cerebrospinal fluid samples were collected before treatment and 8 and 24 hours after treatment. Using polyacrylamide gel electrophoresis and immunoblotting, SBDPs were isolated and compared between groups using computer-assisted densitometric scanning. Necrotic versus apoptotic cell death was indexed by measuring calpain and caspase-3 cleaved alphaII-SBDPs (SBDP 145+150 and SBDP 120, respectively). RESULTS: Animals undergoing HCA demonstrated mild patterns of histologic cellular injury and clinically detectable neurologic dysfunction. Calpain-produced alphaII-SBDPs (150 kDa+145 kDa bands-necrosis) 8 hours after HCA were significantly increased (p = 0.02) as compared with levels before HCA, and remained elevated at 24 hours after HCA. In contrast, caspase-3 alphaII-SBDP (120 kDa band-apoptosis) was not significantly increased. Animals receiving cardiopulmonary bypass did not demonstrate clinical or histologic evidence of injury, with no increases in necrotic or apoptotic cellular markers. CONCLUSIONS: We report the use of alphaII-SBDPs as markers of neurologic injury after cardiac surgery. Our analysis demonstrates that calpain- and caspase-produced alphaII-SBDPs may be an important and novel marker of neurologic injury after HCA.
BACKGROUND: The development of specific biomarkers to aid in the diagnosis and prognosis of neuronal injury is of paramount importance in cardiac surgery. Alpha II-spectrin is a structural protein abundant in neurons of the central nervous system and cleaved into signature fragments by proteases involved in necrotic and apoptotic cell death. We measured cerebrospinal fluid alpha II-spectrin breakdown products (alphaII-SBDPs) in a canine model of hypothermic circulatory arrest (HCA) and cardiopulmonary bypass. METHODS:Canine subjects were exposed to either 1 hour of HCA (n = 8; mean lowest tympanic temperature 18.0 +/- 1.2 degrees C) or standard cardiopulmonary bypass (n = 7). Cerebrospinal fluid samples were collected before treatment and 8 and 24 hours after treatment. Using polyacrylamide gel electrophoresis and immunoblotting, SBDPs were isolated and compared between groups using computer-assisted densitometric scanning. Necrotic versus apoptotic cell death was indexed by measuring calpain and caspase-3 cleaved alphaII-SBDPs (SBDP 145+150 and SBDP 120, respectively). RESULTS: Animals undergoing HCA demonstrated mild patterns of histologic cellular injury and clinically detectable neurologic dysfunction. Calpain-produced alphaII-SBDPs (150 kDa+145 kDa bands-necrosis) 8 hours after HCA were significantly increased (p = 0.02) as compared with levels before HCA, and remained elevated at 24 hours after HCA. In contrast, caspase-3alphaII-SBDP (120 kDa band-apoptosis) was not significantly increased. Animals receiving cardiopulmonary bypass did not demonstrate clinical or histologic evidence of injury, with no increases in necrotic or apoptotic cellular markers. CONCLUSIONS: We report the use of alphaII-SBDPs as markers of neurologic injury after cardiac surgery. Our analysis demonstrates that calpain- and caspase-produced alphaII-SBDPs may be an important and novel marker of neurologic injury after HCA.
Authors: R Beer; G Franz; A Srinivasan; R L Hayes; B R Pike; J K Newcomb; X Zhao; E Schmutzhard; W Poewe; A Kampfl Journal: J Neurochem Date: 2000-09 Impact factor: 5.372
Authors: J G Shake; E A Peck; E Marban; V L Gott; M V Johnston; J C Troncoso; J M Redmond; W A Baumgartner Journal: Ann Thorac Surg Date: 2001-12 Impact factor: 4.330
Authors: Brian R Pike; Jeremy Flint; Jitendra R Dave; X-C May Lu; Kevin K K Wang; Frank C Tortella; Ronald L Hayes Journal: J Cereb Blood Flow Metab Date: 2004-01 Impact factor: 6.200
Authors: Robert Siman; Tracy K McIntosh; Kristie M Soltesz; Zhaoming Chen; Robert W Neumar; Victoria L Roberts Journal: Neurobiol Dis Date: 2004-07 Impact factor: 5.996
Authors: Thomas Muley; Werner Ebert; Petra Stieber; Hannelore Raith; Stefan Holdenrieder; Dorothea Nagel; Heinrich Fürst; Hans-Jürgen Roth; Hilmar Luthe; Bert G Blijenberg; Eberhard Gurr; Wolfgang Uhl; Joachim von Pawel; Peter Drings Journal: Clin Chem Lab Med Date: 2003-01 Impact factor: 3.694
Authors: Heather Romine; Katherine M Rentschler; Kaitlan Smith; Ayanna Edwards; Camille Colvin; Karen Farizatto; Morgan C Pait; David Butler; Ben A Bahr Journal: Eur Sci J Date: 2017-10
Authors: George J Arnaoutakis; Timothy J George; Kevin K Wang; Mary Ann Wilson; Jeremiah G Allen; Chase W Robinson; Kara A Haggerty; Eric S Weiss; Mary E Blue; Charles C Talbot; Juan C Troncoso; Michael V Johnston; William A Baumgartner Journal: J Thorac Cardiovasc Surg Date: 2011-10 Impact factor: 5.209
Authors: Parag Jain; Michael C Spaeder; Mary T Donofrio; Pranava Sinha; Richard A Jonas; Richard J Levy Journal: Pediatr Crit Care Med Date: 2014-03 Impact factor: 3.624
Authors: Mary E Blue; Mary Ann Wilson; Claude A Beaty; Timothy J George; George J Arnaoutakis; Kara A Haggerty; Melissa Jones; Jeffrey Brawn; Shaliza Manmohan; Mary S Lange; Michael V Johnston; William A Baumgartner; Juan C Troncoso Journal: J Neuropathol Exp Neurol Date: 2014-12 Impact factor: 3.685
Authors: Jeremiah G Allen; Eric S Weiss; Mary Ann Wilson; George J Arnaoutakis; Mary E Blue; C Conover Talbot; Chunfa Jie; Mary S Lange; Juan C Troncoso; Michael V Johnston; William A Baumgartner Journal: Ann Thorac Surg Date: 2010-06 Impact factor: 4.330
Authors: Ellen R Lubbers; Nathaniel P Murphy; Hassan Musa; Claire Yu-Mei Huang; Rohan Gupta; Morgan V Price; Mei Han; Georges Daoud; Daniel Gratz; Mona El Refaey; Xianyao Xu; Nicole K Hoeflinger; Emma L Friel; Peter Lancione; Michael J Wallace; Omer Cavus; Samantha L Simmons; Jordan L Williams; Michel Skaf; Sara N Koenig; Paul M L Janssen; Matthew N Rasband; Thomas J Hund; Peter J Mohler Journal: J Biol Chem Date: 2019-05-07 Impact factor: 5.157